|
|
(One intermediate revision not shown.) |
Line 3: |
Line 3: |
| <StructureSection load='4zdx' size='340' side='right'caption='[[4zdx]], [[Resolution|resolution]] 2.00Å' scene=''> | | <StructureSection load='4zdx' size='340' side='right'caption='[[4zdx]], [[Resolution|resolution]] 2.00Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[4zdx]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Aciba Aciba]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZDX OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ZDX FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4zdx]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Acinetobacter_baumannii Acinetobacter baumannii]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZDX OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4ZDX FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=TOE:2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXYL'>TOE</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.001Å</td></tr> |
- | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=KCX:LYSINE+NZ-CARBOXYLIC+ACID'>KCX</scene></td></tr> | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=KCX:LYSINE+NZ-CARBOXYLIC+ACID'>KCX</scene>, <scene name='pdbligand=TOE:2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXYL'>TOE</scene></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4zdx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4zdx OCA], [http://pdbe.org/4zdx PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4zdx RCSB], [http://www.ebi.ac.uk/pdbsum/4zdx PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4zdx ProSAT]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4zdx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4zdx OCA], [https://pdbe.org/4zdx PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4zdx RCSB], [https://www.ebi.ac.uk/pdbsum/4zdx PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4zdx ProSAT]</span></td></tr> |
| </table> | | </table> |
| + | == Function == |
| + | [https://www.uniprot.org/uniprot/Q5QT35_ACIBA Q5QT35_ACIBA] |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
Line 24: |
Line 26: |
| __TOC__ | | __TOC__ |
| </StructureSection> | | </StructureSection> |
- | [[Category: Aciba]] | + | [[Category: Acinetobacter baumannii]] |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Antunes, N T]] | + | [[Category: Antunes NT]] |
- | [[Category: Frase, H]] | + | [[Category: Frase H]] |
- | [[Category: Kantardjieff, K A]] | + | [[Category: Kantardjieff KA]] |
- | [[Category: Smith, C A]] | + | [[Category: Smith CA]] |
- | [[Category: Stewart, N K]] | + | [[Category: Stewart NK]] |
- | [[Category: Toth, M]] | + | [[Category: Toth M]] |
- | [[Category: Vakulenko, S B]] | + | [[Category: Vakulenko SB]] |
- | [[Category: Antibiotic resistance]]
| + | |
- | [[Category: Beta-lactamase]]
| + | |
- | [[Category: Carbapenemase]]
| + | |
- | [[Category: Hydrolase]]
| + | |
- | [[Category: Mutant]]
| + | |
| Structural highlights
Function
Q5QT35_ACIBA
Publication Abstract from PubMed
Class D beta-lactamases of Acinetobacter baumannii are enzymes of the utmost clinical importance, producing resistance to last resort carbapenem antibiotics. Although the OXA-51-like enzymes constitute the largest family of class D beta-lactamases, they are poorly studied and their importance in conferring carbapenem resistance is controversial. We present the detailed microbiological, kinetic, and structural characterization of the eponymous OXA-51 beta-lactamase. Kinetic studies show that OXA-51 has low catalytic efficiency for carbapenems, primarily due to the low affinity of the enzyme for these substrates. Structural studies demonstrate that this low affinity results from the obstruction of the enzyme active site by the side chain of Trp222, which presents a transient steric barrier to an incoming carbapenem substrate. The Trp222Met substitution relieves this steric hindrance and elevates the affinity of the mutant enzyme for carbapenems by 10-fold, significantly increasing the levels of resistance to these antibiotics. The ability of OXA-51 to evolve into a robust carbapenemase as the result of a single amino acid substitution may, in the near future, elevate the ubiquitous enzymes of the OXA-51 family to the status of the most deleterious A. baumannii carbapenemases, with dire clinical consequences.
Structural Basis for Enhancement of Carbapenemase Activity in the OXA-51 Family of Class D beta-Lactamases.,Smith CA, Antunes NT, Stewart NK, Frase H, Toth M, Kantardjieff KA, Vakulenko S ACS Chem Biol. 2015 Jun 12. PMID:26042471[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Smith CA, Antunes NT, Stewart NK, Frase H, Toth M, Kantardjieff KA, Vakulenko S. Structural Basis for Enhancement of Carbapenemase Activity in the OXA-51 Family of Class D beta-Lactamases. ACS Chem Biol. 2015 Jun 12. PMID:26042471 doi:http://dx.doi.org/10.1021/acschembio.5b00090
|